These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24233388)

  • 21. Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial.
    Gage BF; Bass AR; Lin H; Woller SC; Stevens SM; Al-Hammadi N; Anderson JL; Li J; Rodriguez T; Miller JP; McMillin GA; Pendleton RC; Jaffer AK; King CR; Whipple B; Porche-Sorbet R; Napoli L; Merritt K; Thompson AM; Hyun G; Hollomon W; Barrack RL; Nunley RM; Moskowitz G; Dávila-Román V; Eby CS
    JAMA; 2019 Sep; 322(9):834-842. PubMed ID: 31479138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the safety and efficacy of warfarin in Taiwanese patients.
    Kuo LN; Liou JP; Chen HY; Chiang YC; Wu MT
    Int J Clin Pharmacol Ther; 2013 Feb; 51(2):106-13. PubMed ID: 23351596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term treatment with warfarin in Chinese population.
    Chenhsu RY; Chiang SC; Chou MH; Lin MF
    Ann Pharmacother; 2000 Dec; 34(12):1395-401. PubMed ID: 11144695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.
    Hylek EM; Chang YC; Skates SJ; Hughes RA; Singer DE
    Arch Intern Med; 2000 Jun; 160(11):1612-7. PubMed ID: 10847254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis.
    Grzymala-Lubanski B; Svensson PJ; Renlund H; Jeppsson A; Själander A
    Heart; 2017 Feb; 103(3):198-203. PubMed ID: 27590664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic.
    Cao H; Wu J; Zhang J
    Int J Clin Pharm; 2018 Oct; 40(5):1072-1077. PubMed ID: 29956134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR.
    Sandén P; Renlund H; Svensson PJ; Själander A
    Thromb Haemost; 2017 Jan; 117(1):27-32. PubMed ID: 27652593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
    Kearon C; Ginsberg JS; Kovacs MJ; Anderson DR; Wells P; Julian JA; MacKinnon B; Weitz JI; Crowther MA; Dolan S; Turpie AG; Geerts W; Solymoss S; van Nguyen P; Demers C; Kahn SR; Kassis J; Rodger M; Hambleton J; Gent M;
    N Engl J Med; 2003 Aug; 349(7):631-9. PubMed ID: 12917299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of warfarin dosing in the intensive care unit following the Fontan procedure.
    Thomas CA; Taylor K; Schamberger MS; Rotta AT
    Congenit Heart Dis; 2014; 9(4):361-5. PubMed ID: 25247218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.
    Hylek EM; Regan S; Go AS; Hughes RA; Singer DE; Skates SJ
    Ann Intern Med; 2001 Sep; 135(6):393-400. PubMed ID: 11560452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aniticoagulation in patients following prosthetic heart valve replacement.
    Akhtar RP; Abid AR; Zafar H; Khan JS
    Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):10-7. PubMed ID: 19262444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?
    You JH; Chan FW; Wong RS; Cheng G
    Br J Clin Pharmacol; 2005 May; 59(5):582-7. PubMed ID: 15842557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-Analysis Evaluating the Efficacy and Safety of Low-Intensity Warfarin for Patients >65 Years of Age With Non-Valvular Atrial Fibrillation.
    Kang F; Ma Y; Cai A; Cheng X; Liu P; Kuang J; Mai Z; Mai W
    Am J Cardiol; 2021 Mar; 142():74-82. PubMed ID: 33307015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users.
    Witt DM; Delate T; Clark NP; Martell C; Tran T; Crowther MA; Garcia DA; Ageno W; Hylek EM;
    J Thromb Haemost; 2010 Apr; 8(4):744-9. PubMed ID: 20398186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohort.
    Liu S; Singer A; McAlister FA; Peeler W; Heran BS; Drummond N; Manca DP; Allan GM; Korownyk C; Kolber MR; Greiver M; Garrison SR
    Can Fam Physician; 2019 Jun; 65(6):416-425. PubMed ID: 31189630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trial.
    Kampouraki E; Avery PJ; Wynne H; Biss T; Hanley J; Talks K; Kamali F
    Br J Haematol; 2017 Sep; 178(5):800-809. PubMed ID: 28771671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of uninterrupted low-intensity warfarin for cryoballoon ablation of atrial fibrillation in the elderly: A pilot study.
    Xing Y; Xu B; Sheng X; Xu C; Peng F; Sun Y; Wang S; Guo H
    J Clin Pharm Ther; 2018 Jun; 43(3):401-407. PubMed ID: 29484682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated Prothrombin Complex Concentrate versus Plasma for Reversal of Warfarin-Associated Hemorrhage.
    Rowe AS; Mahbubani PS; Bucklin MH; Clark CT; Hamilton LA
    Pharmacotherapy; 2016 Nov; 36(11):1132-1137. PubMed ID: 27726162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [INTERNATIONAL NORMALIZED RATIO VALUES AND HEMORRHAGE IN HOSPITALIZED PATIENTS STARTING WARFARIN THERPY: AN OBSERVATIONAL STUDY].
    Abadi U; Ellis MH
    Harefuah; 2015 Aug; 154(8):490-3, 541-2. PubMed ID: 26480611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.